User menu

Lack of efficacy with 3 oral dose levels of TMI-005 (Apratastat), in subjects with active rheumatoid arthritis on a background of methotrexate-A phase 2 double-blind, placebo-controlled, parallel, randomized study

Bibliographic reference Fleischman, R. ; Durez, Patrick ; Genovese, M. ; Keystone, E. M. ; Pavelka, L. ; et. al. Lack of efficacy with 3 oral dose levels of TMI-005 (Apratastat), in subjects with active rheumatoid arthritis on a background of methotrexate-A phase 2 double-blind, placebo-controlled, parallel, randomized study.Annual European Congress of Rheumatology (EULAR 2006) (Amsterdam (Netherlands), Jun 21-24, 2006). In: Annals of the Rheumatic Diseases, Vol. 65, p. 339-339 (2006)
Permanent URL http://hdl.handle.net/2078.1/59841